Navigation Links
Inovio Biomedical's DNA Delivery Technology Shows Safety and,Enhances Gene Expression & Tumor Responses in Interim Melanoma,Clinical Study Results

further clinical study results to potentially establish Inovio's DNA delivery technology as the delivery method of choice for localized administration of DNA treatments."

Enrollment of this study has been completed and further results are expected in the second half of 2007.

About Inovio's Immunotherapy Products

DNA-based immunotherapy products have the potential to by-pass inherent scientific obstacles of conventional vaccines that prevent their development for cancer and chronic infectious diseases such as HIV and hepatitis C. Pre-clinical data has indicated the potential ability of Inovio's technologies to safely and effectively deliver and significantly enhance the potency of such immunotherapies.

Inovio's DNA-based immunotherapy products consist of DNA plasmids and the Elgen and MedPulser DNA delivery systems. DNA plasmids are designed to express antigens that can induce an immune response specific to a cancer or infectious disease-causing organism. These plasmids are created synthetically and readily manufactured using well-established bacterial fermentation and purification technology. After a plasmid is delivered into muscle or tumor cells, production of the desired antigens may then induce a preventive or therapeutic immune response against the targeted disease. Inovio's advanced electroporation devices facilitate delivery and expression of such immunotherapies and have been shown in primate studies to boost antibody and T-cell immune response by orders of magnitude over DNA plasmid alone, suggesting the potential to provide better protection from complex infectious diseases such as HIV and hepatitis C as well as cancers such as prostate and breast cancers.

Inovio is poised to deliver advanced DNA-based immunotherapies, devices and know-how in this rapidly advancing field. The company is actively licensing its technology to pharmaceutical and biotechnology companies and supporting early stage clinical studies arising from
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
2. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
3. Inovio: DNA delivery technology shows positive human results
4. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
5. Inovio Biomedicals DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine
6. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
10. PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin A at European Cystic Fibrosis Conference
11. News from the Battlefield of Metastatic Cancer: Epeius Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G) from the Stone of Chemistry and Physics
Post Your Comments:
(Date:11/26/2014)... , Nov. 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Jaffray Healthcare Conference in New York ... PDT . Dr. Helen Torley , President and ... The presentation will be webcast through the "Investors" section of ... will be made available for 90 days following the event. ...
(Date:11/24/2014)... 2014  CryoLife, Inc. (NYSE: CRY ), a ... and vascular surgery, announced today that it will participate in ... on Wednesday, December 3, 2014 at The New York Palace ... A live webcast of the Company,s presentation is scheduled ... overview of the company by Pat Mackin , President ...
(Date:11/24/2014)... MONTREAL , Nov. 24, 2014 /PRNewswire/ - Milestone ... clinical trial conducted in Melbourne, Australia ... antagonist for the potential treatment of paroxysmal supraventricular ... formulation of MSP-2017 was well tolerated at single ... an excellent safety profile, desirable PK properties including ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
... , , ... (Nasdaq: IPCM ), a leading national hospitalist physician group practice ... was named by ACP Hospitalist as one of the ... the November 2009 issue of the magazine. , Dr. Vaidyan has ...
... VIEW, Calif., Nov. 24 Satellite Healthcare, one of the ... a major sponsor of nephrology research, today announced its full ... his effort to support the San Jose homeless this Thanksgiving ... chef for the past 20 years. But Nasrallah,s life was ...
Cached Medicine Technology:IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 3Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... Vultures have developed highly specialized ways of dealing with ... researchers report. The new research investigated the different ... the guts of 50 turkey vultures and black vultures ... the vultures had more than 500 different types of ... found. The findings suggest that a vulture,s digestive ...
(Date:11/26/2014)... to peanut protein in household dust may increase the ... condition eczema, a new study reveals. About 2 ... allergic to peanuts. And severe eczema in infants has ... researchers noted. The new study included 359 infants ... the amount of peanut protein the children were exposed ...
(Date:11/26/2014)... News) -- Parents need to take an active role ... warns. Parents must make sure sports-playing teens have ... Dodick, chair of the American Migraine Foundation and a ... Medicine in Scottsdale, Ariz. in an American Migraine Foundation, ... coach involved with teens sports needs to have appropriate ...
(Date:11/24/2014)... 24, 2014 The Healthy Skin Care ... of affordable skin care products, recently announced its launch. ... readers a wide variety of articles, tips, and evaluations ... organic skincare alternatives. , According to Emily Lataille, the ... content includes thoroughly researched reviews, tips for the skin, ...
Breaking Medicine News(10 mins):Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2
... , BETHESDA, Md., Nov. 16 GetWellNetwork, Inc. ... chief operating officer. Ms. Perry, an experienced high-tech leader and ... level of growth and deliver on the promise of improving ... Among her priorities, Ms. Perry will focus on GetWellNetwork,s leadership ...
... extended-release niacin, or Niaspan , SUNDAY, Nov. 15 (HealthDay ... ezetimibe (Zetia), a drug used by millions of Americans ... cholesterol. , The trial, known as ARBITER-6 HALTS, was ... LDL-cholesterol-lowering Zetia was less effective than extended-release niacin (Niaspan), ...
... 16 Blue Water Spa, a Raleigh NC Day Spa and ... party and Raleigh food drive. Guests who donate frozen turkeys or ... receive a $10,000 spa gift certificate for luxury spa services. , ... on hand Wed. November 18 and Saturday December 12 to accept ...
... YORK, Nov. 16 Nearly every household has some sort of ... like. But how many people plan ahead for dental emergencies? ... leading provider of oral care products, although one in six Americans ... not prepared to deal with the problem. , "You keep ...
... ... researchers with online cognitive rehab tools for cognitive impairments caused by Alzheimer,s disease, Traumatic ... ... HAPPYneuron PRO, a suite of online cognitive rehab tools for a variety ...
... ... Socks for Kids who Wear Ankle-Foot Orthoses (AFOs) , ... Westchester, NY (PRWEB) November 16, 2009 -- Ross Daniel Adaptive ... marketplace debut and the launch of “Cool Clothes for Toes,” the first creatively styled sock ...
Cached Medicine News:Health News:GetWellNetwork Taps High-Tech Veteran Michele Perry as Chief Operating Officer 2Health News:Study Raises New Questions About Cholesterol Drug Zetia 2Health News:Study Raises New Questions About Cholesterol Drug Zetia 3Health News:Raleigh Day Spa, Blue Water Spa, Raffles Off $10,000 in Day Spa Packages for Contributing to Raleigh Food Drive 2Health News:Be Prepared for a Dental Emergency During the Holidays 2Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 2Health News:HAPPYneuron Launches Beta Program for Innovative Cognitive Rehab Tools at AMIA Conference in San Francisco 3Health News:Ross Daniel Adaptive Apparel Announces Company Debut and 'Cool Clothes for Toes' 2Health News:Ross Daniel Adaptive Apparel Announces Company Debut and 'Cool Clothes for Toes' 3
The PowerLab/4ST is a high-performance recording unit with built-in amplifiers and is suitable for physiology teaching. It has been designed to cover the broad experimental requirements in life scien...
... The PowerLab/4SP is a high-performance data acquisition ... research applications including human and animal physiology, ... engineering. The unit is capable of recording ... (up to 200 000 samples per second ...
Worth 4-Dot Flashlight/Plastic for testing and training of visual functions and testing for fusion, suppression and/or diplopia. Red/green goggle included. Requires 2 C batteries (not included)....
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
Medicine Products: